BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2725863)

  • 1. Modulation of hypothalamic cholecystokinin receptor density with changes in magnocellular activity: a quantitative autoradiographic study.
    Day NC; Hall MD; Hughes J
    Neuroscience; 1989; 29(2):371-83. PubMed ID: 2725863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations.
    Meister B; Villar MJ; Ceccatelli S; Hökfelt T
    Neuroscience; 1990; 37(3):603-33. PubMed ID: 1701038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical evidence for the presence of a mutant vasopressin precursor in the supraoptic nucleus of the homozygous Brattleboro rat.
    Guldenaar SE; Nahke P; Pickering BT
    Cell Tissue Res; 1986; 244(2):431-6. PubMed ID: 3719667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin-deficient paraventricular magnocellular neurons of homozygous Brattleboro rats synthesize neuropeptide Y.
    Kagotani Y; Hisano S; Tsuruo Y; Daikoku S; Chihara K
    Neurosci Lett; 1990 Apr; 112(1):37-42. PubMed ID: 2385361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of 125I-cholecystokinin-octapeptide in the paraventricular but not the supraoptic nucleus is increased by ovariectomy.
    Akesson TR; Micevych PE
    Brain Res; 1986 Oct; 385(1):165-8. PubMed ID: 3768715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cholecystokinin receptors in the hypothalamus of the rat: reciprocal changes in magnocellular nuclei induced by food deprivation and dehydration.
    O'Shea RD; Gundlach AL
    J Neuroendocrinol; 1993 Dec; 5(6):697-704. PubMed ID: 8680444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge.
    Sherman TG; Day R; Civelli O; Douglass J; Herbert E; Akil H; Watson SJ
    J Neurosci; 1988 Oct; 8(10):3785-96. PubMed ID: 2903913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular localization and differential distribution of GABAA receptor subunit proteins and messenger RNAs within hypothalamic magnocellular neurons.
    Fenelon VS; Sieghart W; Herbison AE
    Neuroscience; 1995 Feb; 64(4):1129-43. PubMed ID: 7753380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin B receptor gene expression in hypothalamic neurosecretory neurons after experimental manipulations.
    Meister B; Broberger C; Villar MJ; Hökfelt T
    Neuroendocrinology; 1994 Nov; 60(5):458-69. PubMed ID: 7845536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of cholecystokinin and oxytocin-neurophysin in some magnocellular hypothalamo-hypophyseal neurons.
    Vanderhaeghen JJ; Lotstra F; Vandesande F; Dierickx K
    Cell Tissue Res; 1981; 221(1):227-31. PubMed ID: 7032704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered cholecystokinin binding site density in the supraoptic nucleus of morphine-tolerant and -dependent rats.
    Munro G; Pumford KM; Russell JA
    Brain Res; 1998 Jan; 780(2):190-8. PubMed ID: 9507122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of oestrogen receptor-beta mRNA expression in rat paraventricular and supraoptic nucleus neurones following adrenal steroid manipulation and hyperosmotic stimulation.
    Somponpun SJ; Holmes MC; Seckl JR; Russell JA
    J Neuroendocrinol; 2004 May; 16(5):472-82. PubMed ID: 15117341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical activation and c-fos mRNA expression in rat neurosecretory neurones after systemic administration of cholecystokinin.
    Hamamura M; Leng G; Emson PC; Kiyama H
    J Physiol; 1991 Dec; 444():51-63. PubMed ID: 1822561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release.
    Moos F; Freund-Mercier MJ; Guerné Y; Guerné JM; Stoeckel ME; Richard P
    J Endocrinol; 1984 Jul; 102(1):63-72. PubMed ID: 6539805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of estrogen receptor immunoreactivity in the oxytocin-containing magnocellular neurons projecting to the neurohypophysis in the guinea-pig.
    Warembourg M; Poulain P
    Neuroscience; 1991; 40(1):41-53. PubMed ID: 1646976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro.
    Jarvis CR; Bourque CW; Renaud LP
    J Physiol; 1992 Dec; 458():621-32. PubMed ID: 1302281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurokinin B receptor (NK3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline.
    Ding YQ; Lü BZ; Guan ZL; Wang DS; Xu JQ; Li JH
    Neuroscience; 1999; 91(3):1077-85. PubMed ID: 10391485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine hydroxylase in magnocellular neurosecretory neurons. Response to physiological manipulations.
    Kiss JZ; Mezey E
    Neuroendocrinology; 1986; 43(4):519-25. PubMed ID: 2427963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of kappa opioid receptors in oxytocin magnocellular neurons in the paraventricular and supraoptic nuclei.
    Smith MJ; Wise PM
    Brain Res; 2001 Apr; 898(1):162-5. PubMed ID: 11292460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential distribution of acetylcholinesterase activity among vasopressin- and oxytocin-containing supraoptic magnocellular neurons.
    Pow DV; Morris JF
    Neuroscience; 1989; 28(1):109-19. PubMed ID: 2761686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.